MSN 570 Advanced Pathophysiology Final 2024 Related

Review MSN 570 Advanced Pathophysiology Final 2024 related questions and content

Women who have breast cancer due to a BRCA1 gene mutation are usually:

  • A. positive for human epidermal growth factor receptor 1 and 2.
  • B. negative for estrogen receptor.
  • C. positive for estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2.
  • D. negative for estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2.
Correct Answer: D

Rationale: Women with breast cancer due to a BRCA1 gene mutation commonly have a triple-negative breast cancer subtype, which means they are negative for estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 (HER2). This subtype tends to be more aggressive and harder to treat. Choice A is incorrect as they are typically negative for HER2. Choice B is incorrect because they are usually negative for estrogen receptor. Choice C is incorrect as they are usually negative for progesterone receptor and HER2.